New onset of Juvenile Dermatomyositis during Tumor Necrosis Factor Inhibitor (Adalimumab) Therapy
Saved in:
| Main Authors: | Sunil V Kapur, Jitendra S Oswal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-01-01
|
| Series: | Indian Journal of Rheumatology |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=1;spage=86;epage=88;aulast=Kapur |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab
by: Yuri Vladimirovich Muravyev, et al.
Published: (2013-06-01) -
EFFICACY OF USE OF TNF INHIBITOR ADALIMUMAB IN A FEMALE PATIENT WITH CHRONIC UVEITIS IN THE ONSET OF JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Pavkhun, et al.
Published: (2016-02-01) -
Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
by: Sunil Kapur, et al.
Published: (2021-01-01) -
A rare case of primary antiphospholipid antibody-associated chorea in a child
by: Sunil V Kapur, et al.
Published: (2020-01-01) -
Atypical presentation of Wiskott–Aldrich syndrome with autoimmune arthritis and macrothrombocytopenia
by: Sunil Vishan Kapur, et al.
Published: (2021-01-01)